Overview of Clofenak

Quick Facts	Description
Active Ingredient	Diclofenac (INN)
Form	Tablet, Capsule, Injection, Suppository, Topical Gel
Pharmacological Class	Nonsteroidal Anti-inflammatory Drug (NSAID)
Common Use	Relief of pain, inflammation, and fever
Origin	Synthetic compound (Phenylacetic acid derivative)

Defining Clofenak: An NSAID and Phenylacetic Acid Derivative

Clofenak is a trade name for a medicinal product centered on the active ingredient Diclofenac, which is formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This designation places it in a class of widely used medicines recognized for their efficacy in managing both pain and inflammatory processes. Diclofenac is a synthetic compound derived from phenylacetic acid. As a cornerstone agent in non-opioid pain management, Diclofenac is utilized in various forms. This chemical origin distinguishes its structure from common NSAIDs like ibuprofen.

Core Purpose and Triple Action of Diclofenac

The essential purpose of Diclofenac is defined by its powerful three-fold physiological action: it functions as a potent anti-inflammatory agent, an effective analgesic (pain reliever), and an acknowledged antipyretic (fever reducer). It achieves these effects by acting as a non-selective cyclooxygenase (COX) inhibitor, a mechanism that reduces the body’s production of inflammatory chemicals called prostaglandins. Diclofenac is used to treat pain and inflammation. The medication is designed to help relieve common discomfort associated with processes like acute injury or muscle strain.

Forms of Diclofenac and Single-Ingredient Nature

Diclofenac is typically supplied as a single-ingredient product, maximizing the therapeutic impact of the core compound. The medicine is manufactured across various dosage form(s) to ensure flexibility in application, including oral preparations such as tablets and capsules, as well as forms suitable for localized relief, such as topical gels and suppositories. This variation allows for the medicine to achieve either broad systemic action or targeted peripheral analgesic action, with the choice of route of administration often being a key differentiating factor in patient care.

What side effects are possible with Clofenak?

Possible Side Effects and Safety Information

The safety profile for Clofenak, which contains the NSAID diclofenac, is defined by classifications of adverse reactions documented in official government regulatory labels.

General Safety Classifications

Adverse effects are grouped by the affected body system and frequency. Reactions classified as Common often involve the Gastrointestinal System (e.g., nausea, abdominal pain, diarrhea, elevated liver enzymes) and the Nervous System (headache, dizziness). Serious adverse events are typically classified as Rare or Very Rare.

Serious Adverse Reactions and Key Regulatory Constraints

Regulatory documents emphasize two major systemic risks associated with the medicine, which can occur at any time during use, sometimes without warning:

Cardiovascular Thrombotic Events: The use of diclofenac, particularly in high doses and long-term treatment, is associated with an increased risk of serious events like myocardial infarction (heart attack) and stroke. This risk may occur early in treatment and increases with duration of use.
Gastrointestinal Complications: There is a heightened risk of serious adverse events, including bleeding, ulceration, or perforation of the stomach or intestines.

Population and Time-Related Safety Notes

Specific populations have documented safety considerations. Older adults are at a greater risk for serious gastrointestinal adverse events. Use is generally contraindicated or avoided in patients with established severe cardiovascular disease and during the third trimester of pregnancy. Furthermore, the risk of serious skin reactions (like Stevens-Johnson Syndrome) is noted to be highest at the beginning of therapy.

Official prescribing information prohibits the use of Clofenak for treating perioperative pain after coronary artery bypass graft (CABG) surgery.

Overdose and Emergency Response

Overdose and when to seek help

Immediate medical attention is required for any suspected overdose of Clofenak (Diclofenac). Contact the local emergency number or a Poison Control Center right away, as dictated by official regulatory guidance. The management of an overdose focuses on professional supportive care due to the documented potential for severe outcomes.

Manifestations Documented in Labeling	Severe/Life-Threatening Outcomes
Gastrointestinal: Nausea, vomiting (potentially bloody), diarrhea, stomach pain.	Organ Damage: Acute renal failure, liver failure.
Neurological: Drowsiness, dizziness, headache, confusion, blurred vision.	Neurological Events: Seizures, coma.
Systemic: High or low blood pressure, increased heart rate, edema.	Major Hemorrhage: Severe gastrointestinal bleeding.

Regulatory documents confirm that no specific antidote is known to counteract Diclofenac toxicity. Consequently, emergency actions often include administering supportive measures like activated charcoal for recent ingestions and providing fluids through a vein. Hospital monitoring is required, including the assessment of vital signs and diagnostic procedures such as blood and urine tests, a chest x-ray, and an electrocardiogram (ECG) to monitor for potential systemic and organ damage. Increased risk for severe effects is noted for patients with pre-existing hepatic or renal impairment.

Therapeutic Uses of Clofenak

What Clofenak Treats: Main Uses and Benefits

Clofenak is commonly used across domains where additional symptomatic support is needed for pain, inflammation, and fever, helping to ease the overall symptom burden. It is relevant in clinical settings that involve acute or disruptive symptom patterns, and is applied across conditions that produce significant symptomatic burden.

Comprehensive Symptom Relief

This medication is applied in addressing symptoms related to inflammatory or irritative states, including the pain and stiffness associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also applied in scenarios where additional management of discomfort is required for conditions like acute musculoskeletal injuries, dysmenorrhea, migraine headaches, and may assist with the reduction of fever.

In providing symptomatic relief, Clofenak may help patients cope more steadily with symptom fluctuations during difficult episodes.

“This medication is primarily relevant for easing symptoms that interfere with daily comfort, supporting general well-being during symptomatic phases.”

Quick Fact: Relief for Pain, Inflammation, and Fever

Quick Fact	Description
Primary Target	Symptoms related to physical discomfort and inflammatory states
Acute Use	Supports relief in cases of acute pain and swelling (e.g., sprains)
Benefit	Contributes to improved comfort during periods of heightened symptoms

The medication provides supportive relief when symptoms interfere with routine activities, and may assist with maintaining functional stability during periods of increased distress or discomfort.

Regulatory References

NIH StatPearls overview on Diclofenac

Eligibility and Restrictions for Use

Who can and cannot use Clofenak? — Official Regulatory Information

The eligibility for using Clofenak, whose active ingredient is Diclofenac (an NSAID), is strictly defined by regulatory agencies based on a patient’s health status, age, and physiological state. The following groups are classified as ineligible or require special caution, as stated in official labeling:

Classification	Population/Condition
Absolute Contraindications	History of asthma, hives, or allergic reactions after taking aspirin or other NSAIDs.
	Active gastrointestinal bleeding, ulceration, or perforation.
	In the setting of coronary artery bypass graft (CABG) surgery.
	Established Congestive Heart Failure (NYHA Class II-IV) or other severe cardiovascular disease.
	Severe renal or severe hepatic impairment.
	Pregnancy: Beginning at approximately 30 weeks gestation (third trimester) [FDA].
Use Not Established	Most children under 12 years of age for systemic (oral) formulations.
Conditional Restrictions	Older Adults (Geriatric): Permitted, but official labeling requires caution due to increased vulnerability to GI bleeding and kidney issues.
	Mild to Moderate Impairment: Patients with mild or moderate renal or hepatic impairment.
	Pregnancy (Early-Stage): Not recommended between 20 and 30 weeks gestation unless necessary [FDA].

What should I know about interactions with other medicines?

Clofenak (diclofenac), as a nonsteroidal anti-inflammatory drug (NSAID), can interact with several other medications, increasing the risk of serious side effects like gastrointestinal bleeding or kidney problems. It is crucial to inform your doctor or pharmacist about all medications and supplements you are currently taking.

Key Drug Interactions

Interacting Medicine Category	Potential Result of Interaction
Other NSAIDs (e.g., ibuprofen, naproxen) and Aspirin	Significantly increased risk of serious gastrointestinal side effects (ulcers, bleeding). Avoid concurrent use.
Anticoagulants (Blood Thinners) and Antiplatelets (e.g., Warfarin, Clopidogrel)	Greatly increased risk of serious bleeding. Requires close monitoring or avoidance.
Blood Pressure Medications (e.g., ACE inhibitors, ARBs, Diuretics)	May reduce the effectiveness of blood pressure drugs and increase the risk of kidney damage.
Selective Serotonin Reuptake Inhibitors (SSRIs) and Steroids (e.g., Prednisone)	Increased risk of gastrointestinal bleeding.
Methotrexate or Lithium	Clofenak can increase the concentration of these drugs in the blood, leading to toxicity. Dose adjustment or monitoring is necessary.

Other Important Considerations

Combining Clofenak with alcohol may increase the risk of stomach bleeding. Herbal supplements like Ginkgo Biloba may also increase the risk of bleeding. Always check the ingredients of over-the-counter cold and pain relief products, as many contain other NSAIDs.

Mechanism of Action

Modulation via Cyclooxygenase Enzyme Inhibition

The action of Clofenak is centered on modulating specific molecular pathways to adjust physiological responses. Its primary action is the competitive inhibition of the Cyclooxygenase (COX) enzymes, targeting both COX-1 and COX-2. By binding to the active site, Clofenak halts the conversion of the fatty acid precursor, arachidonic acid, into pro-inflammatory prostaglandins and other lipid mediators. This molecular suppression modifies early steps in the signaling cascade, resulting in a systemic shift toward decreased local fluid accumulation and lowered peripheral nociceptor sensitization.

Central and Peripheral Signaling Cascade Control

Clofenak engages in a dual action by modulating signaling both at the site of tissue dysregulation and within the central nervous system (CNS). Its presence in the hypothalamus helps to reset the body's elevated temperature set-point by preventing PGE2 synthesis in that region. This targeted interference with prostaglandin-driven pathways contributes to the modulation of targeted physiological responses, resulting in adjustments in core body temperature and decreased peripheral nociceptor responsiveness.

Dosage and Administration Information

Administration Scope and Dosing Constraints

Clofenak (Diclofenac) is administered via multiple routes, which include oral preparations (tablets, capsules, solutions), parenteral injection (intramuscular and intravenous), rectal suppositories, and topical gels. The specific route selection determines the dosage form and the subsequent administration rules.

Standard adult dosing regimens for chronic conditions like arthritis typically utilize oral doses ranging from 50 mg to 75 mg taken in divided doses, or 100 mg for extended-release forms taken once daily. The maximum daily dose for oral administration varies by formulation but is generally between 150 mg and 225 mg. The general practice is to use the lowest effective dosage for the shortest duration necessary for all forms.

Contextual Instructions and Procedural Structure

Specific oral formulations, such as the powder for solution, must be taken on an empty stomach and diluted only with a small amount of water. In contrast, delayed-release tablets are often advised to be swallowed whole and may be taken before meals. A key procedural restriction is that delayed-release and extended-release tablets must not be crushed, chewed, or divided. Parenteral administration, used for acute, short-term treatment, is limited to a maximum duration of two days, and intravenous solutions require mandatory dilution and buffering before infusion. If a regular dose is missed, the procedure is to skip the missed dose and take the next one at the regularly scheduled time.

Recent Clinical Evidence

Clofenak: Recent Clinical Evidence

Clinical trials, predominantly randomized, double-blind, placebo-controlled studies, have been conducted to evaluate the drug's effect on pain and inflammation in patients with Condition Z.

Study Findings and Effectiveness Measures

Findings included the reporting of changes in symptom severity measures compared to placebo. Secondary analyses investigated the duration of effect, with one trial including the measurement of initial responses during the first two hours of administration. The studies assessed the effects of various dose levels and explored the potential influence of combination therapy on patient outcomes.

Tolerability and Safety Profile

The overall safety profile was assessed across all clinical trials. The most frequently reported adverse events included nausea, mild headache, and fatigue. These events were reported to be mild to moderate in severity and did not typically lead to discontinuation from the studies.

Drug-Food Interaction: Research examined the drug’s absorption in the presence of food.

Investigated Use in Specific Populations

Trials reported the incidence of adverse events in the general population studied. Research excluded or limited participation for individuals with severe kidney impairment; thus, suitability for this group is not clearly established. Data regarding use in pediatric patients and pregnant individuals remains limited, as these groups were generally excluded from the primary efficacy trials. Further studies may be needed to explore the profile in these populations.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Clofenak (FAQ)

Q: How quickly does Clofenak usually start to work?

According to official product information, the onset of absorption after taking an oral dose may involve a delay, typically ranging between one to four and a half hours. However, peak blood levels are generally reached relatively quickly after the medicine begins to be absorbed. The exact time it takes to feel relief can depend on the specific formulation being used.

Q: How long do the effects of one dose of Clofenak last?

Studies examining the drug’s elimination from the body indicate that the medicine's half-life is approximately 1.2 to 2 hours. Clinical trials for acute pain suggest that the effect of a standard dose can last up to 6–8 hours, though this duration may vary depending on the specific dosage and type of product.

Q: Can people with high blood pressure take Clofenak?

Official warnings state that nonsteroidal anti-inflammatory drugs (NSAIDs) like Clofenak can sometimes lead to new or worsening cases of high blood pressure (hypertension). For this reason, regulatory documents describe the need for close monitoring of individuals with high blood pressure while they are undergoing treatment with this medication.

Q: Is there a maximum time someone can continuously use Clofenak?

Regulatory guidance consistently emphasizes that the lowest effective dose should be used for the shortest duration necessary to control symptoms. For certain specific, short-term uses, such as injectable forms for acute pain, treatment duration may be strictly limited to one or two days.

Q: Is Clofenak similar to aspirin?

Clofenak's active ingredient, diclofenac, belongs to the same class of drugs as aspirin: Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Because of this shared classification, official guidelines state that Clofenak is contraindicated (use is not permitted) in patients who have a history of allergic reactions, asthma, or hives after taking aspirin or other NSAIDs.

Q: What is the difference between brand-name Clofenak and the generic version?

Brand-name Clofenak and its generic versions contain the identical active ingredient (Diclofenac). Regulatory agencies ensure that generic drugs meet strict standards for bioequivalence, meaning they are absorbed by the body at the same rate and extent as the brand-name product. The main difference is that generic versions may have different inactive ingredients and are typically lower cost.

Q: What is the purpose of the black box warning (if any) associated with Clofenak?

In the United States, official product labels include a Boxed Warning to highlight the most serious risks. For Clofenak, this warning alerts patients and prescribers to the potential for an increased risk of serious Cardiovascular (CV) thrombotic events (like heart attack and stroke) and serious Gastrointestinal (GI) adverse events (like bleeding or ulcers).

Q: What is the general expectation for pain relief level with Clofenak?

Studies on acute pain management have indicated that certain doses of diclofenac provided effective pain relief when compared against a placebo. The evidence suggests the medication is associated with a high level of effective pain relief among study participants who used it for its intended purpose.

Q: Is Clofenak available without a prescription in some countries?

Regulatory status for Clofenak varies globally by country and product type. In some regions, oral forms of diclofenac have been reclassified as prescription-only medicines (POM) due to concerns over cardiovascular side effects. However, lower-strength topical products, such as gels, often remain available for purchase without a prescription.

Q: Does Clofenak have a risk of addiction?

Clofenak is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Official safety information indicates that this class of medication is not associated with the risk of physical dependence or addiction.

Q: Is Clofenak known to affect sleep?

Official adverse event reports occasionally include effects on the Nervous System such as insomnia (difficulty sleeping) and drowsiness.

Q: Can Clofenak be used by people who are trying to get pregnant?

Regulatory information indicates that taking anti-inflammatory medicines like Clofenak in large doses or for a long time can potentially affect ovulation. Patients actively trying to conceive or undergoing fertility tests may need to discuss the necessity of continuing this medication, as it has been noted to potentially make conception more difficult.

Q: Does Clofenak have any warnings about driving or operating machinery?

Because some individuals may experience side effects such as dizziness, drowsiness, or visual disturbances, regulatory documents advise caution. Official patient information advises that patients may need to refrain from driving or operating machinery until they know how the medicine affects their ability to perform these tasks safely.

Q: Why do official documents mention taking Clofenak with food?

While certain specific formulations are meant to be taken on an empty stomach for better absorption, delayed-release forms may be advised to be taken with or before meals. This is often recommended to help reduce the potential for stomach upset or irritation that can occur when taking this type of medication.

Q: Why is it important to know if I have asthma before taking Clofenak?

Clofenak is contraindicated (use is not permitted) in patients with asthma who are sensitive to aspirin or other NSAIDs. Regulatory documents note this absolute restriction because using the drug in this specific patient group carries a risk of severe, potentially fatal bronchospasm (narrowing of the airways) and serious allergic reactions.

Q: What are the warning signs of a serious allergic reaction to Clofenak?

Official regulatory information lists several warning signs of a serious allergic reaction. These can include swelling of the face, lips, tongue, or throat, hives, or trouble breathing. Serious skin reactions may also manifest as a blistering rash accompanied by fever or red, stinging eyes.

Q: Does Clofenak interfere with birth control pills?

Official medical information indicates that Clofenak is not expected to affect the function of hormonal contraceptives. This includes the combined pill, the progestogen-only pill, and emergency contraception.

Q: Does using Clofenak increase sensitivity to the sun?

Official warnings note a risk of photosensitivity, which is an increased sensitivity to sunlight or UV radiation, especially with topical formulations. Due to this potential, patient information often includes recommendations for protective measures against sun exposure while the medicine is being used.

Q: Are there specific symptoms that Clofenak is generally not used to treat?

Official prescribing information states that Clofenak is not indicated for the prophylactic (preventative) therapy of typical migraine headaches or for use in cluster headaches. Furthermore, its use is prohibited for treating pain following coronary artery bypass graft (CABG) surgery.

Q: How does Clofenak compare to acetaminophen (paracetamol)?

Clofenak is classified as an NSAID, which means it has three actions: anti-inflammatory, analgesic (pain reliever), and antipyretic (fever reducer). In contrast, acetaminophen (paracetamol) is classified as an analgesic and antipyretic but official pharmacological sources state that it does not possess significant anti-inflammatory effects.

Q: What evidence exists about Clofenak's use in pain management after dental surgery?

Clinical trials focusing on acute postoperative pain have included studies following surgical procedures such as dental surgery. These studies indicate that certain formulations are associated with a high level of effective pain relief in this specific setting compared to placebo.

How should Clofenak be stored and disposed of?

How to Store and Dispose of Clofenak?

Clofenak (diclofenac) must be stored and disposed of according to official regulatory conditions to ensure stability and safety.

Storage Environment and Container Rules

Oral tablets require storage at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with permitted excursions. Products must be stored in a tight and light-resistant container and require protection from moisture. Certain topical formulations must be stored below 30 C and must not freeze.

Protection and Disposal

A mandatory requirement is to keep all forms out of the reach of children and pets to prevent accidental ingestion. For disposal, any unused or expired product must be discarded in accordance with local requirements. Used topical patches must be specifically folded and placed in the trash immediately after use, ensuring the adhesive sides stick together.

Clofenak